1. T-Cell Activation and the Three-Signal Hypothesis

Mature, naive CD4+ and CD8+ T cells leave the thymus and enter the systemic circulation. To transition from a quiescent, naive state into fully functional effector or memory cells, these T cells must encounter their cognate antigens within the microenvironment of secondary lymphoid organs. This activation process is governed by the Three-Signal Hypothesis, requiring coordinated molecular interactions at the immunological synapse.

Figure: The Three-Signal Model of T-Cell Activation. Signal 1 is delivered when the TCR-CD3 complex recognizes peptide–MHC on the APC; Signal 2 is delivered when CD28 engages B7 (CD80/CD86); Signal 3 is delivered by autocrine/paracrine IL-2 acting on the upregulated IL-2 receptor (CD25), driving clonal expansion and differentiation.

Signal 1: TCR-CD3 Antigenic Recognition

• Interaction
  Molecular Interaction

  The highly variable T-Cell Receptor (TCR) heterodimer (αβ or γδ) binds to the foreign peptide antigen accommodated within the peptide-binding cleft of a Major Histocompatibility Complex (MHC) molecule on an Antigen-Presenting Cell (APC).

  • CD4+ T cells bind peptide–MHC Class II complexes.
  • CD8+ T cells bind peptide–MHC Class I complexes.
• Machinery
  Transduction Machinery

  Because the short cytoplasmic tails of TCR α and β chains lack signaling motifs, signal transduction is mediated by the non-covalently associated CD3 complex (consisting of γε, δε heterodimers and a ζζ homodimer). The cytoplasmic domains of the CD3 chains contain Immunoreceptor Tyrosine-based Activation Motifs (ITAMs). Upon TCR engagement, these ITAMs are phosphorylated by the Src-family kinase Lck, initiating the downstream signaling cascade.

Signal 2: The Costimulatory Interaction

Antigenic recognition (Signal 1) in the absence of costimulation results in clonal anergy (functional unresponsiveness) or apoptosis.

• Ligands
  Key Ligands

  The principal costimulatory signal is delivered by the B7 family proteins expressed on the surface of activated, professional APCs (such as dendritic cells, macrophages, and B cells).

  • CD80 (B7-1) and CD86 (B7-2) are upregulated on APCs in response to pathogen recognition via innate PRRs.
• Receptor
  T-Cell Receptor

  The constitutive receptor for B7 on naive T cells is CD28, a 44 kDa homodimeric glycoprotein.

• Outcome
  Functional Outcome

  CD28 signaling cooperates with TCR signaling to promote cell survival, trigger metabolic reprogramming (glycolytic switch), and drive the transcription of the crucial survival and proliferation cytokine IL-2 and its high-affinity receptor subunit (CD25 / IL-2Rα).

Signal 3: Cytokine Signaling

• Mechanism
  Mechanism

  Soluble polarizing cytokines present in the local microenvironment bind to specific cell-surface cytokine receptors on the T cell.

• Outcome
  Functional Outcome

  This signal initiates specific JAK-STAT signaling pathways that dictate the differentiation program of the T cell, directing it to mature into a highly specialized effector lineage. IL-2 acts as a critical autocrine and paracrine growth factor, driving rapid clonal expansion.

Accessory Adhesion Molecules

To stabilize the physical contact between the T cell and the APC (facilitating the formation of the "immunological synapse" or supramolecular activation cluster [SMAC]), several pairs of non-antigen-specific adhesion molecules interact:

2. CD4+ T Helper (T_H) Cell Subsets and Cross-Regulation

Upon activation, naive CD4+ T_H cells (often designated as T_H0 cells) differentiate into distinct effector subsets. This lineage commitment is dictated by the specific combination of polarizing cytokines secreted by APCs and neighboring innate cells during initial priming. Each subset is defined by a master transcription factor, a signature cytokine profile, and distinct immunological functions.

Figure: T_H0 Lineage Commitment. The specific combination of polarizing cytokines present during priming (top row) drives naive CD4+ T_H0 cells toward one of five major effector fates, each defined by a master transcription factor (middle row) and a signature cytokine output (bottom row): T_H1 (T-bet), T_H2 (GATA3), T_H17 (RORγt), T_FH (Bcl-6), and T_REG (FoxP3).

The Lineage Matrix

Molecular Mechanisms of Cross-Regulation

To ensure a coordinated and appropriate immune response, the developmental pathways of T_H1 and T_H2 cells mutually inhibit each other through a process known as cross-regulation:

• Th1 → Th2
  T_H1-mediated Inhibition

  The signature cytokine of T_H1 cells, IFN-γ, directly inhibits the proliferation and GATA3-driven differentiation of the T_H2 lineage. Furthermore, IFN-γ stimulates APCs to secrete IL-12, which further drives T_H1 development in a positive feedback loop.

• Th2 → Th1
  T_H2-mediated Inhibition

  The signature cytokine of T_H2 cells, IL-4, acts directly on naive CD4+ T cells to downregulate the expression of the IL-12 receptor β₂ chain, rendering them unresponsive to IL-12 and thus blocking T_H1 differentiation.

• Indirect
  IL-10-mediated Control

  Secreted by T_H2 (and T_REG) cells, IL-10 inhibits the production of IL-12 by APCs, indirectly suppressing the induction of the T_H1 pathway.

3. Cytotoxic T Lymphocyte (CTL) Effector Mechanisms

Naive CD8+ T cells (T_C cells) are activated by antigenic peptide–MHC Class I complexes in the presence of costimulation and helper T cell-derived cytokines (such as IL-2 and IFN-γ). Once activated, they proliferate and differentiate into mature, armed Cytotoxic T Lymphocytes (CTLs). CTLs are highly efficient "killer" cells that target and destroy infected or neoplastic cells through two primary, highly coordinated cytotoxic pathways.

Figure: The CTL–Target Cell Synapse. An armed CTL engages a target cell across the immunological synapse and can trigger apoptosis through two independent, coordinated routes — the granule-dependent Perforin/Granzyme pathway and the receptor-mediated Fas/FasL pathway — both of which converge on caspase activation and target cell death.

Pathway A: The Perforin–Granzyme Cytolytic Pathway

This is the primary pathway utilized by CTLs, relying on the directed release of specialized lytic granules across the immunological synapse in a calcium-dependent manner.

• Step 1
  Conjugate Formation

  The CTL TCR-CD3 complex and CD8 coreceptor bind the cognate peptide–MHC Class I complex on the target cell. Adhesion molecules (LFA-1/ICAM-1) tighten the contact, creating an isolated intercellular space (synapse).

• Step 2
  Granule Reorientation

  Microtubule organizing centers (MTOCs) and Golgi bodies within the CTL polarize toward the contact site. Cytolytic granules travel along microtubules to align precisely at the immunological membrane.

• Step 3
  Exocytosis

  Upon Ca²⁺ influx, granule membranes fuse with the CTL plasma membrane, discharging their cargo into the immunological synapse.

  • Perforin: a pore-forming monomeric protein. In the presence of extracellular Ca²⁺, perforin polymerizes within the target cell membrane, forming functional hydrophilic pores or facilitating target cell endocytosis of the granule components.
  • Granzymes: serine proteases (primarily Granzyme B) that enter the target cell cytoplasm.
• Step 4
  Apoptotic Cascade Execution

  Once inside the target cell cytosol, Granzyme B initiates multiple apoptotic pathways.

  • Direct Caspase Activation: Granzyme B cleaves and activates Procaspase-3 and Procaspase-7, the primary executioner caspases.
  • Mitochondrial Pathway (Amplification): Granzyme B cleaves Bid (a pro-apoptotic Bcl-2 family member) to tBid (truncated Bid). tBid translocates to the outer mitochondrial membrane, inducing oligomerization of Bax/Bak. This causes the release of Cytochrome c into the cytosol, where it associates with Apaf-1 and Procaspase-9 to form the apoptosome, activating Caspase-9 which subsequently activates Caspase-3.
  • DNA Fragmentation: Caspase-3 cleaves ICAD (Inhibitor of Caspase-Activated DNase), releasing the active endonuclease CAD. CAD translocates to the nucleus and cleaves genomic DNA at internucleosomal linker regions, generating characteristic 200-base-pair DNA fragments.

Figure: Granzyme B-Induced Apoptotic Cascade. Granzyme B triggers two convergent routes to Caspase-3: a direct route (cleaving Procaspase-3/7) and a slower mitochondrial amplification route (Bid → tBid → Bax/Bak oligomerization → Cytochrome c release → apoptosome → Caspase-9). Active Caspase-3 then cleaves ICAD to release CAD, which translocates to the nucleus and cleaves genomic DNA into the characteristic ~200 bp fragmentation ladder of apoptosis.

Pathway B: The Fas–FasL (CD95/CD178) Cytolytic Pathway

This receptor-ligand-mediated pathway triggers extrinsic apoptotic signaling independent of lytic granules.

• Step 1
  Receptor Engagement

  Activated CTLs transiently express Fas Ligand (FasL, CD178), a homotrimeric transmembrane protein belonging to the TNF superfamily. This ligand binds to Fas (CD95), a death-domain-containing receptor constitutively expressed on many target cell types.

• Step 2
  Trimerization & Adapter Recruitment

  Binding of trimeric FasL induces the trimerization of Fas on the target cell. This conformational change clusters the cytoplasmic Death Domains (DD) of Fas, recruiting the adapter protein FADD (Fas-Associated Death Domain) via homotypic DD-DD interactions.

• Step 3
  DISC Assembly

  FADD contains a Death Effector Domain (DED) that subsequently recruits Procaspase-8 (and/or Procaspase-10) to form the DISC (Death-Inducing Signaling Complex).

• Step 4
  Caspase Activation

  Concentration of Procaspase-8 molecules at the DISC results in auto-proteolytic cleavage, releasing active Caspase-8 into the cytoplasm. Caspase-8 directly cleaves and activates executioner Caspase-3, or cleaves Bid to initiate the mitochondrial apoptotic pathway.

Figure: Fas–FasL Signaling Cascade. FasL on the CTL binds and trimerizes Fas on the target cell, clustering cytoplasmic Death Domains that recruit FADD and assemble the DISC. Concentrated Procaspase-8 at the DISC undergoes auto-proteolytic cleavage into active Caspase-8, which either directly activates executioner Caspase-3 or cleaves Bid to feed into the same mitochondrial amplification loop used by the Perforin/Granzyme pathway — illustrating the molecular convergence of both cytotoxic routes.

4. NK and NKT Cell Biology

Natural Killer (NK) cells and Natural Killer T (NKT) cells occupy the critical evolutionary boundary between innate and adaptive immunity, providing rapid protection against virally infected and neoplastic cells.

Figure: NK Cell Activation Thresholds. NK cell behavior reflects the net balance of inhibitory and activating signals. (A) On healthy cells, MHC-I engages inhibitory receptors, which dominate and block lysis. (B) When MHC-I is absent or downregulated ("missing-self"), inhibitory receptors go unengaged and baseline activating signals trigger degranulation. (C) Under severe cellular stress ("induced-self"), activating ligands are so strongly upregulated that they overwhelm inhibitory signaling even when MHC-I is present.

Natural Killer (NK) Cells

NK cells are large granular lymphocytes belonging to the innate lymphoid cell (ILC) lineage. They lack rearranged, antigen-specific TCRs or immunoglobulins, and their activation is governed by a precise integration of signals from activating and inhibiting surface receptors.

1. Activating and Inhibiting Receptors

• Inhibiting
  Inhibiting Receptors

  These receptors recognize classical MHC Class I molecules (HLA-A, HLA-B, HLA-C in humans; H-2K, H-2D, H-2L in mice) constitutively expressed on all healthy, nucleated self-cells.

  • Mechanism: Inhibitory receptors contain Immunoreceptor Tyrosine-based Inhibitory Motifs (ITIMs) in their cytoplasmic tails. Upon binding MHC-I, these ITIMs are phosphorylated and recruit tyrosine phosphatases (such as SHP-1), which dephosphorylate and inactivate signaling molecules downstream of activating receptors.
• Activating
  Activating Receptors

  These receptors recognize ligands associated with cellular distress, viral infection, or DNA damage.

  • Key Receptors: NKG2D (recognizes MICA, MICB, and ULBP proteins in humans), and natural cytotoxicity receptors (such as NKp30, NKp44, NKp46).
  • Mechanism: Activating receptors associate with adapter chains containing intracellular ITAMs (such as DAP12 or the CD3 ζ chain), which transduce stimulatory signals.

2. Effector Activation Hypotheses

• Hypothesis 1
  The Missing-Self Hypothesis

  Many viruses and tumor cells selectively downregulate MHC Class I expression on the host cell surface to escape detection by CD8+ CTLs. When an NK cell encounters such a cell, the absence of MHC-I leaves its inhibitory receptors unengaged. The baseline activating signals are no longer suppressed, triggering NK cell activation, degranulation (releasing perforin and granzymes), and target cell lysis.

• Hypothesis 2
  The Induced-Self Hypothesis

  Under conditions of extreme cellular stress (e.g., DNA damage, physical injury, or oncogenic transformation), host cells dramatically upregulate ligands for activating receptors (such as NKG2D ligands). The strength of this activating signal is sufficient to overwhelm the MHC Class I-mediated inhibitory signal, driving NK cell activation.

3. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)

NK cells express high levels of FcγRIII (CD16), a low-affinity receptor for the Fc region of IgG antibodies (specifically IgG1 and IgG3 subclasses). When host target cells are infected by a pathogen and express foreign viral proteins on their surface, host-derived IgG antibodies coat these targets. CD16 on the NK cell binds the clustered Fc portions of these bound antibodies, inducing potent receptor cross-linking that triggers immediate degranulation and osmotic/apoptotic lysis of the target cell.

Figure: ADCC Mechanism. IgG antibodies bind viral antigens on an infected target cell via their Fab arms, leaving their Fc regions exposed. CD16 (FcγRIII) on the NK cell binds these clustered Fc regions, and the resulting receptor cross-linking triggers degranulation independent of the activating/inhibiting receptor balance shown above.

Natural Killer T (NKT) Cells

NKT cells represent a distinct, hybrid lineage of lymphocytes expressing both NK cell markers (e.g., NK1.1 or CD56) and a semi-invariant αβ T-Cell Receptor (TCR).

• Pathway
  Antigen Presentation Pathway

  Unlike conventional T cells that recognize peptide antigens presented on classical MHC Class I or II, NKT cells recognize foreign and self lipid, glycolipid, and hydrophobic antigens.

• Molecule
  The CD1d Molecule

  Lipid antigens are presented to NKT cells on CD1d, a non-classical MHC Class I-like molecule that is non-polymorphic.

• Subsets
  Subsets

  Invariant NKT (iNKT) cells express a highly restricted, semi-invariant TCR (α chain: Vα14-Jα18 in mice, Vα24-Jα18 in humans, paired with a restricted set of Vβ chains).

• Function
  Effector Function

  Upon activation (classically stimulated experimentally by the marine sponge-derived glycolipid α-galactosylceramide), NKT cells rapidly secrete vast quantities of both T_H1-polarizing cytokines (IFN-γ) and T_H2-polarizing cytokines (IL-4), acting as a powerful cellular bridge to modulate downstream adaptive immunity.

Figure: NKT Cell Function. Lipid or glycolipid antigen presented on CD1d engages the NKT cell's semi-invariant TCR. Unlike conventional T_H subsets, a single activated NKT cell simultaneously secretes both T_H1-polarizing IFN-γ and T_H2-polarizing IL-4, allowing it to rapidly shape the character of the downstream adaptive response.